Abiopharma

Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026

HyOrc Provides Indicative Methanol Production Cost Range and Commercial Positioning Following Technology Validation

TeraWulf Announces Participation in Upcoming Investor and Industry Conferences

CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100

Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares

Notification from Dominari Holdings Inc

Panoro Announces Upsized $21MM Financing

Register of shareholders, changes and capital status - central report - exercise of employee warrants

FSK DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds FS KKR Capital (FSK) Investors of Securities Class Action Deadline on July 3, 2026

Xtreme One Entertainment Adds Seasoned Public Company Exec as CEO & Expands Leadership Team Depth to Scale its Fast-Growing MMA Business